Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | APP | P05067 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | STAT3 | P40763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26143205 | 0.95 | CYP3A4 (0.34) | CYP3A4PDK2CYP2C9APPS1PR1 | |
| SCHEMBL26143195 | 0.94 | CYP3A4 (0.35) | CYP3A4PDK2CYP2C9APPCYP2D6 | |
| SCHEMBL26143214 | 0.94 | CYP3A4 (0.35) | CYP3A4PDK2CYP2C9APPCYP2D6 | |
| SCHEMBL26143208 | 0.94 | PDK2 (0.34) | CYP3A4PDK2CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL26143150 | 0.94 | CYP3A4 (0.37) | CYP3A4PDK2CYP2C9APPCYP2D6 | |
| SCHEMBL26143215 | 0.92 | CYP3A4 (0.34) | CYP3A4PDK2CYP2C9APPSTAT3 | |
| SCHEMBL26143196 | 0.92 | PDK2 (0.34) | CYP3A4PDK2CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL26143317 | 0.92 | CYP3A4 (0.34) | CYP3A4PDK2CYP2C9APP | |
| SCHEMBL23691275 | 0.92 | CYP3A4 (0.35) | CYP3A4PDK2CYP2C9APPCYP2D6 | |
| SCHEMBL23691199 | 0.92 | PDK2 (0.38) | CYP3A4PDK2STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230157155-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| US-20230157155-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157155-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | CRY1, SLC1A2, CHRM1 | CYP3A4 1552/4885PDK2 1154/4885CYP2C9 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.